Subtotal $0.00
Shop Now
Ozempic heartburn is a recognized but usually uncommon side effect. In the Ozempic trials, reflux (gastroesophageal reflux disease, or GERD) was reported by about 1.5% to 1.9% of people versus none on placebo, and indigestion by about 3%. Rates are higher with the weight-management medicines: on Wegovy, 5% of adults reported reflux versus 3% on placebo and 9% reported indigestion versus 3%, and Zepbound shows a similar pattern. A likely contributor is that these medicines slow how fast the stomach empties. Simple habits, such as finishing meals at least three hours before lying down, help many people with reflux. Crushing chest pain, trouble swallowing or vomiting blood needs urgent care, and anyone taking these medicines should tell the care team before surgery or sedation.
Peptide Labs does not sell Ozempic, Wegovy, Mounjaro, Zepbound or any prescription drug. This article summarizes FDA labels and National Institutes of Health guidance. For every effect reported across the class, see our guide to GLP-1 medicine side effects.
Key Takeaways
- Ozempic label: reflux in about 1.5% to 1.9% of people versus 0% on placebo.
- Wegovy label: reflux 5% versus 3%, indigestion 9% versus 3% and belching 7% versus under 1%.
- Zepbound label: reflux 4% to 5% versus 2%; indigestion 9% to 10% versus 4%.
- These medicines delay stomach emptying, which may add to fullness, belching and reflux.
- NIH advice: finish meals at least three hours before lying down and raise the head of the bed.
- Crushing chest pain could be a heart attack: get help immediately.
How common is Ozempic heartburn? Label rates by drug
The labels do not use the word heartburn in their tables. They count gastroesophageal reflux disease, dyspepsia (indigestion or upper stomach discomfort) and eructation (belching), which overlap with what most people call heartburn. Ranges reflect the different strengths studied.
| Drug (approved use) | Reflux (GERD) | Indigestion | Belching | Label revision |
|---|---|---|---|---|
| Ozempic (type 2 diabetes) | 1.5% to 1.9% vs 0% | 2.7% to 3.5% vs 1.9% | 1.1% to 2.7% vs 0% | May 2026 |
| Wegovy injection, adults (weight management) | 5% vs 3% | 9% vs 3% | 7% vs under 1% | June 2026 |
| Mounjaro (type 2 diabetes) | 1.7% to 2.5% vs 0.4% | 5% to 8% vs 3% | 2.5% to 3.3% vs 0.4% | August 2026 |
| Zepbound (weight management) | 4% to 5% vs 2% | 9% to 10% vs 4% | 4% to 5% vs 1% | August 2026 |
Two patterns stand out. First, the absolute numbers are modest: even on Wegovy, about 95 in 100 adults did not report reflux. Second, the weight-management versions show higher rates than the diabetes versions, in line with the higher rates of other digestive effects in those trials. Placebo rates remind us that reflux is common anyway; not every episode on these medicines is caused by them.
Wegovy heartburn, belching and indigestion
Wegovy heartburn is spelled out in plain words in the patient leaflet: the Wegovy Medication Guide lists heartburn, belching and upset stomach among the most common side effects in adults and children 12 and older. In the adolescent trial, reflux was reported by 4% versus 2% on placebo and belching by 4% versus none. The adult table also shows gastritis, a group that includes reflux gastritis, in 4% versus 1%.
Belching often travels with reflux. If burps smell of rotten eggs, our guide to sulfur-smelling burps explains the causes. If queasiness is the bigger problem, see nausea on Ozempic.
Why GLP-1 GERD symptoms happen
The labels do not give a mechanism for GLP-1 GERD symptoms, but they do describe a likely contributor. Each of these four labels states that the medicine delays gastric emptying, meaning food stays in the stomach longer. A fuller stomach for longer can mean more pressure, more belching and more chance of acid moving back up into the esophagus, especially after a large or fatty meal or when lying down soon after eating.
The effect may not stay the same over time. The Zepbound label says the delay in stomach emptying is largest after the first injection and diminishes over time, and the Ozempic label describes the delay as mainly in the early period after a meal. Digestive side effects in general are reported most often while the strength is being increased, which is why prescribers step it up gradually.
Severe stomach problems are a separate matter. The Ozempic label warns that digestive reactions are sometimes severe, reported in 0.4% to 0.8% of trial participants versus none on placebo, and says the medicine is not recommended for people with severe gastroparesis (a condition in which the stomach empties very slowly). Tell your prescriber about any history of stomach emptying problems.
Ozempic acid reflux: everyday steps from NIH guidance
There is no trial of reflux habits specifically in people taking GLP-1 medicines, so the steps below come from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) general advice for Ozempic acid reflux and other reflux. Your prescriber may add others.
- Time meals. If symptoms come at night or when lying down, NIDDK suggests eating meals at least three hours before you lie down or go to bed.
- Raise your head. A foam wedge or extra pillows under the head and upper back can raise the head 6 to 8 inches.
- Notice triggers. NIDDK lists citrus fruits and tomatoes, alcohol, chocolate, coffee and other caffeine, high-fat foods, mint and spicy foods as foods that may make symptoms worse.
- Eat smaller meals. A 2025 joint nutrition advisory on GLP-1 therapy recommends regular small meals; stopping when you feel full also avoids an overfilled stomach. Our eating guide for GLP-1 medicines has practical ideas.
- Quit smoking, if you smoke, which NIDDK also recommends for reflux.
Be careful with mint remedies. Peppermint is often suggested for an upset stomach, but NCCIH lists heartburn among the possible side effects of peppermint oil taken by mouth, and NIDDK names mint as a possible reflux trigger. Our article on what the evidence says about peppermint covers this in more detail.
Ask a pharmacist before starting an over-the-counter heartburn medicine. GLP-1 labels note that slower stomach emptying may affect how other medicines taken by mouth are absorbed, and a pharmacist can check the fit with everything else you take.
Heartburn, anesthesia and procedures
In November 2024 the FDA added a warning to GLP-1 labels about pulmonary aspiration, when stomach contents are breathed into the lungs, during general anesthesia or deep sedation. The current labels describe rare reports of this in people who still had food in the stomach despite following fasting instructions. They also say there is not enough data to know whether changing fasting rules or pausing the medicine lowers the risk.
What the labels do say is simple: tell every healthcare provider, including the anesthesiologist, surgeon or endoscopy team, that you take the medicine before any planned procedure. Do not change or pause it on your own; the prescriber and procedure team decide together. Mention ongoing reflux or vomiting too, because a stomach that empties slowly is part of their planning.
Red flags: when heartburn needs medical help
MedlinePlus, the National Library of Medicine’s consumer health site, warns that heartburn with crushing chest pain could be a heart attack and to get help immediately. NIDDK advises seeing a doctor for:
- Trouble swallowing or pain when swallowing.
- Vomiting that keeps happening, or vomit that contains blood.
- Black, tarry stools.
- Chest pain, or reflux symptoms that do not improve with lifestyle changes or over-the-counter medicines.
- Loss of appetite or weight loss beyond what you and your prescriber expect from the medicine.
The GLP-1 Medication Guides add two more: severe stomach pain that will not go away, sometimes spreading to the back, which can signal pancreatitis, and upper stomach pain with fever, yellowing of the skin or eyes or clay-colored stools, which can signal gallbladder problems. Call your prescriber right away for either. More detail by drug is in our guides to semaglutide side effects and Zepbound side effects.
Frequently Asked Questions
Does Ozempic cause heartburn?
It can. The Ozempic label reports reflux in about 1.5% to 1.9% of people versus none on placebo, and indigestion in about 3%. Most people in the trials did not report it.
Is acid reflux more common on Wegovy than on Ozempic?
In the labels, yes. Wegovy trials reported reflux in 5% of adults versus 3% on placebo, and the Wegovy Medication Guide lists heartburn and belching among common side effects.
Why do GLP-1 medicines cause reflux?
The labels do not give a mechanism, but they all state that these medicines delay stomach emptying. Food staying in the stomach longer can add to fullness, belching and reflux.
What helps Ozempic heartburn?
NIH guidance suggests eating at least three hours before lying down, raising the head of the bed, smaller meals and limiting triggers such as fatty or spicy foods, alcohol, caffeine and mint.
Should I tell my surgeon I take Ozempic?
Yes. GLP-1 labels tell patients to inform healthcare providers before any planned surgery or procedure because slower stomach emptying has been linked to rare aspiration during anesthesia.
When is heartburn on a GLP-1 drug an emergency?
Get help immediately for crushing chest pain. See a doctor promptly for trouble swallowing, vomiting blood, black stools or severe stomach pain that will not go away.
Peptide Labs does not sell GLP-1 medicines or any prescription drug. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed October 2026.
Related guides: Sulfur Burps: Causes, Ozempic Burps and When to Worry, Ozempic Nausea: How Long It Lasts and What Helps, GLP-1 Side Effects: What Every GLP-1 Drug Label Warns About.